$TXG

10x Genomics Inc - Class A

$TXG

10x Genomics Inc - Class A

Past 12mo:2mentions2voices

All voices2 mentions since Jan 2026calls only

Loading price chart…

Recent mentions

2 mentions

@tradableastroMar 3, 2026 · 12:31 AM

🚨Leaderboard for the day🚨 📈Top 5 Strongest: $AAOI $ACLX $AEHR $LITE $YOU 📉Top 5 Weakest: $EOSE $MNKD $RUN $GRAL $SHLS ⚡️Newly added to Strongest: $COHR $DELL $DK $FSLY $LITE $NEXA $NTLA $TXG $UAMY 🦥Newly added to Weakest: $AVAV $CRWV $CSIQ $ELV $FSLR $IQ $PLTK $RUN $YINN No more free trials after TONIGHT!

Open on X

@investmentguru_Jan 14, 2026 · 1:54 AM

Key themes to watch: •Early Detection ( $GH, $EXAS ) : AI-driven diagnostics and liquid biopsy remain one of the fastest paths to real-world impact and revenue scalability. •Robotics & Automation ( $ISRG, $RBOT ) : Surgical automation is a long-duration growth story as hospitals push for precision, efficiency, and cost control. •Multi-omics & Genomics ( $TXG, $ILMN, $CRSP, $BEAM $TEM ) : AI + sequencing is accelerating target discovery, personalization, and next-gen therapies. •Virtual Care & Monitoring ( $TDOC, $HIMS ) : AI-driven engagement, triage, and personalization continue to reshape patient access and care delivery. •AI Drug Discovery ( $RXRX, $SDGR, $ABCL ) : Platform-based models remain volatile short term but offer asymmetric upside as pipelines mature. •Infrastructure & Enablers ( $VEEV, $DOCS, $GEHC ) : The “picks and shovels” of AI healthcare adoption.